Event Date/Time: Apr 25, 2004
End Date/Time: Apr 29, 2004
Learn how to accelerate your drug development program and to optimize your manufacturing operations with inside information from industry leaders at TIDES® 2004: IBC’s Oligonucleotide and Peptide Technology Conferences, the most widely praised and well attended event specifically designed for manufacturing and drug development scientists. TIDES® 2004 will discuss leading clinical candidates on Riquent™, Genasense™, Macugen™, and Plenaxis™; strategies and case studies on manufacturing, development, and regulatory; applications of therapeutics, diagnostics, and research; latest delivery technologies of oral, nasal, polymer, cell, and SiRNA; updates on compounds in development; and an inside look into the Aventis/Genta Collaboration. Hear in-depth keynote presentations on Plenaxis™: From Peptide to Approved Pharmaceutical from Malcolm L. Gefter, Ph.D., Praecis Pharmaceuticals Incorporated & Development of Genasense™ for Cancer Therapy from Robert E. Klem, Ph.D., Genta Incorporated. For up-to-date information on this event and to register online, visit www.LifeSciencesInfo.com/TIDES.